skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:054922/0857   Pages: 84
Recorded: 01/07/2021
Attorney Dkt #:ANDEXANET
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 33
1
Patent #:
8455439
Issue Dt:
06/04/2013
Application #:
12616735
Filing Dt:
11/11/2009
Publication #:
US20100125052
Pub Dt:
05/20/2010
Title:
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME IN COMBINATION WITH BLOOD COAGULATING AGENTS
2
Patent #:
8268783
Issue Dt:
09/18/2012
Application #:
12749217
Filing Dt:
03/29/2010
Publication #:
US20100255000
Pub Dt:
10/07/2010
Title:
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
3
Patent #:
9056106
Issue Dt:
06/16/2015
Application #:
12836536
Filing Dt:
07/14/2010
Publication #:
US20110015128
Pub Dt:
01/20/2011
Title:
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
4
Patent #:
9109046
Issue Dt:
08/18/2015
Application #:
13591098
Filing Dt:
08/21/2012
Publication #:
US20130129693
Pub Dt:
05/23/2013
Title:
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
5
Patent #:
NONE
Issue Dt:
Application #:
13766652
Filing Dt:
02/13/2013
Publication #:
US20130230901
Pub Dt:
09/05/2013
Title:
PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR
6
Patent #:
9200268
Issue Dt:
12/01/2015
Application #:
13830372
Filing Dt:
03/14/2013
Publication #:
US20140186923
Pub Dt:
07/03/2014
Title:
COMPOUNDS AND METHODS FOR PURIFICATION OF SERINE PROTEASES
7
Patent #:
NONE
Issue Dt:
Application #:
13874313
Filing Dt:
04/30/2013
Publication #:
US20140134151
Pub Dt:
05/15/2014
Title:
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME IN COMBINATION WITH BLOOD COAGULATING AGENTS
8
Patent #:
NONE
Issue Dt:
Application #:
14142655
Filing Dt:
12/27/2013
Publication #:
US20140346397
Pub Dt:
11/27/2014
Title:
COMPOUNDS AND METHODS FOR PURIFICATION OF SERINE PROTEASES
9
Patent #:
NONE
Issue Dt:
Application #:
14320199
Filing Dt:
06/30/2014
Publication #:
US20150025011
Pub Dt:
01/22/2015
Title:
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
10
Patent #:
NONE
Issue Dt:
Application #:
14378440
Filing Dt:
08/13/2014
Publication #:
US20160015793
Pub Dt:
01/21/2016
Title:
MODULATION OF FACTOR XA INHIBITOR MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
11
Patent #:
NONE
Issue Dt:
Application #:
14406645
Filing Dt:
12/09/2014
Publication #:
US20150239929
Pub Dt:
08/27/2015
Title:
METHOD FOR PURIFICATION OF RECOMBINANT FACTOR XA DERIVATIVES
12
Patent #:
9644195
Issue Dt:
05/09/2017
Application #:
14723395
Filing Dt:
05/27/2015
Publication #:
US20150337285
Pub Dt:
11/26/2015
Title:
COMPOUNDS AND METHODS FOR PURIFICATION OF SERINE PROTEASES
13
Patent #:
NONE
Issue Dt:
Application #:
14745901
Filing Dt:
06/22/2015
Publication #:
US20150376592
Pub Dt:
12/31/2015
Title:
PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR
14
Patent #:
NONE
Issue Dt:
Application #:
14762098
Filing Dt:
07/20/2015
Publication #:
US20150352194
Pub Dt:
12/10/2015
Title:
INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVATIVES
15
Patent #:
9587233
Issue Dt:
03/07/2017
Application #:
14790305
Filing Dt:
07/02/2015
Publication #:
US20160002617
Pub Dt:
01/07/2016
Title:
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
16
Patent #:
NONE
Issue Dt:
Application #:
15136810
Filing Dt:
04/22/2016
Publication #:
US20160237420
Pub Dt:
08/18/2016
Title:
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
17
Patent #:
NONE
Issue Dt:
Application #:
15212105
Filing Dt:
07/15/2016
Publication #:
US20170014492
Pub Dt:
01/19/2017
Title:
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
18
Patent #:
NONE
Issue Dt:
Application #:
15391020
Filing Dt:
12/27/2016
Publication #:
US20170240879
Pub Dt:
08/24/2017
Title:
PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR
19
Patent #:
10190111
Issue Dt:
01/29/2019
Application #:
15435086
Filing Dt:
02/16/2017
Publication #:
US20170233711
Pub Dt:
08/17/2017
Title:
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
20
Patent #:
10604748
Issue Dt:
03/31/2020
Application #:
15626813
Filing Dt:
06/19/2017
Publication #:
US20170369862
Pub Dt:
12/28/2017
Title:
PREPARATION OF FACTOR XA DERIVATIVES
21
Patent #:
NONE
Issue Dt:
Application #:
15820265
Filing Dt:
11/21/2017
Publication #:
US20180320160
Pub Dt:
11/08/2018
Title:
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
22
Patent #:
10765726
Issue Dt:
09/08/2020
Application #:
15833520
Filing Dt:
12/06/2017
Publication #:
US20180236049
Pub Dt:
08/23/2018
Title:
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
23
Patent #:
NONE
Issue Dt:
Application #:
15902886
Filing Dt:
02/22/2018
Publication #:
US20180185459
Pub Dt:
07/05/2018
Title:
MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
24
Patent #:
NONE
Issue Dt:
Application #:
15919014
Filing Dt:
03/12/2018
Publication #:
US20180333469
Pub Dt:
11/22/2018
Title:
INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVATIVES
25
Patent #:
NONE
Issue Dt:
Application #:
16078596
Filing Dt:
08/21/2018
Publication #:
US20190046450
Pub Dt:
02/14/2019
Title:
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
26
Patent #:
NONE
Issue Dt:
Application #:
16127864
Filing Dt:
09/11/2018
Publication #:
US20190127720
Pub Dt:
05/02/2019
Title:
PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR
27
Patent #:
10954503
Issue Dt:
03/23/2021
Application #:
16250870
Filing Dt:
01/17/2019
Publication #:
US20190309279
Pub Dt:
10/10/2019
Title:
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
28
Patent #:
NONE
Issue Dt:
Application #:
16519732
Filing Dt:
07/23/2019
Publication #:
US20200129597
Pub Dt:
04/30/2020
Title:
MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
29
Patent #:
10954504
Issue Dt:
03/23/2021
Application #:
16740001
Filing Dt:
01/10/2020
Publication #:
US20200208131
Pub Dt:
07/02/2020
Title:
PREPARATION OF FACTOR XA DERIVATIVES
30
Patent #:
NONE
Issue Dt:
Application #:
16895443
Filing Dt:
06/08/2020
Publication #:
US20200299667
Pub Dt:
09/24/2020
Title:
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
31
Patent #:
11028382
Issue Dt:
06/08/2021
Application #:
16895448
Filing Dt:
06/08/2020
Publication #:
US20200299668
Pub Dt:
09/24/2020
Title:
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
32
Patent #:
NONE
Issue Dt:
Application #:
16943933
Filing Dt:
07/30/2020
Publication #:
US20210085762
Pub Dt:
03/25/2021
Title:
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
33
Patent #:
NONE
Issue Dt:
Application #:
17254146
Filing Dt:
12/18/2020
Publication #:
US20210371842
Pub Dt:
12/02/2021
Title:
ANTIDOTES TO FACTOR XA INHIBITORS
Assignor
1
ALEXION PHARMA INTERNATIONAL OPERATIONS UNLIMITED COMPANY
Exec Dt:
12/03/2020
Assignee
1
ALEXION PHARMACEUTICALS, INC.
121 SEAPORT BOULEVARD
BOSTON, MASSACHUSETTS 02210
Correspondence name and address
ALEXION PHARMACEUTICALS, INC.
100 COLLEGE STREET
NEW HAVEN, CT 06510

Search Results as of: 05/15/2024 07:59 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT